Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Merry Christmas! Medibank (ASX:MPL) defers premiums for five months

Santa has come early for Medibank Private Ltd (ASX: MPL) customers with the business deferring its premium increase for five months.

The increase is the lowest average premium rise in 21 years.

The Medibank share price is largely unmoved on the news, up just 0.3% to $3.39.

Merry Christmas!

Medibank will return approximately $135 million in COVID-19 net claims savings back to customers, by deferring next year’s premium increases.

The slated 3.10% increase, the lowest average premium rise in 21 years, will be postponed from April 1 to September 1.

It will apply to around 2 million Medibank and AHM policies that hold an active hospital or extras policy at any time over the five-month period.

“Customers will save on average around $93 for hospital and extra policies and around $8 on extra policies”

Building goodwill

Today’s announcement brings the total pandemic support package to $435 million. This is no insubstantial sum, equating to about 6.5% of the company’s revenue in FY21.

Management noted the give back will not impact operating earnings for the first half.

Medibank is also targeting $15 million in cost savings in addition to the $20 million it achieved in FY21.

Since the onset of the pandemic, private health insurers have typically incurred lower than expected claims as elective surgeries were delayed and incidents reduced.

Instead of retaining those savings, the company is choosing to pass that onto customers by pushing out the standard annual fee rise.

Medibank could have cashed the savings, however, has chosen to build goodwill with its existing customer base.

My take

It’s somewhat fitting for Medibank to announce the premium delay two days out from Christmas given its red and white colour scheme.

Today’s announcement is undoubtedly a positive for customers, but what about shareholders? Wouldn’t it be better to retain the net claim savings?

That’s definitely an option. But I think passing on the savings to customers when it doesn’t affect the bottom line is actually a positive for Medibank shareholders.

It’ll likely increase customer retention and goodwill with members.

Conversely, competitor NIB Holdings Limited (ASX: NHF) announced it will increase premiums by 2.66% today with the potential of just a three-month deferral.

If you’re looking for share ideas, don’t miss Owen and Anirban chat about 4 rapidly growing ASX and global stocks for 2022.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Lachlan does not have a financial or commercial interest in any of the companies or funds mentioned.
Skip to content